Ratings
0
Nobody has rated this yet. Be the first!
Works
7
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial
Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients
Überwachtes Lernen zur Prädiktion von Tumorwachstum
How fast is repopulation of tumor cells during the treatment gap?
Identification of serum proteome components associated with progression of non-small cell lung cancer
Mixture model of NMR - its application to diagnosis and treatment of brain cancer
